Corporate Banner
Satellite Banner
Technology Networks Header
Friday, July 25, 2014
Technology Networks
 
Register | Sign in
Home Page > Latest Webcasts
  Webcasts
Scientific News
UK Government Must Do More to Reduce Risk of vCJD Infection
Report recommends that UK Government commission a full assessment of the risks currently faced by the UK blood supply.
Capturing Cancer: A Powerful New Technique for Early Diagnosis
Researchers describe an innovative technique for early disease detection, which they call immunosignaturing.
Significant Step Towards Blood Test for Alzheimer's
Scientists have identified a set of 10 proteins in the blood which can predict the onset of Alzheimer’s, marking a significant step towards developing a blood test for the disease.
Researchers Identify Urgent Need for Alzheimer's Disease Drug Development
Analysis of clinical trials published in the journal Alzheimer's Research & Therapy shows that the pipeline for potential treatments of AD is small and rate of success is limited.
New Tool to Study Critical Protein Interaction in Cancer Research
A*STAR scientists used fluorescent molecular rotors to study protein-protein interactions involving p53 and MDM2 in cells.
Researchers Discover ‘Trojan Horse’ Method
Scientists found a way to deliver proteins into live human cells without harm.
Missing Protein Explains Link Between Obesity and Diabetes
A*STAR scientists pioneered a molecular connection between the two health conditions.
Potential Alzheimer’s Drug Prevents Abnormal Blood Clots in the Brain
Researchers have identified a compound that might halt the progression of Alzheimer’s by interfering with the role of plaque forming amyloid-ß.
CRI Finds Key to Identifying, Enriching Mesenchymal Stem Cells
Biomarker enables researchers to accurately characterize the properties and function of MSCs in the body.
Biologists Find ‘Missing Link’ in the Production of Protein Factories in Cells
Biologists at UC San Diego have found the “missing link” in the chemical system that enables animal cells to produce ribosomes.
Scroll Up
Scroll Down
Return
Mode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics Technologies
Andreas Jenne, CEO, Kinaxo, speaking at European Biomarkers Summit 2011.
Date Posted: Thursday, December 08, 2011
Print Page

For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



KINAXO Extends Collaboration with Takeda
KINAXO will apply its quantitative phosphoproteomics technology PhosphoScout ® to assist in research of drugs under development at Takeda.
Tuesday, April 05, 2011
Kinaxo Enters in to an Agreement with AstraZeneca
Under the terms of the agreement, Kinaxo will apply its quantitative mass spec technology platform to support one of AstraZeneca’s oncology programs.
Wednesday, January 05, 2011
KINAXO Enters Agreement with Bristol-Myers Squibb Company
KINAXO will apply its chemical proteomics technologies to deconvolute molecular targets of compounds undergoing discovery research at BMS.
Friday, October 15, 2010
Kinaxo Extends its Collaboration with Roche
KINAXO will apply its phosphoproteomics technology PhosphoScout® to support targeted treatment approaches currently under development at Roche.
Wednesday, January 13, 2010
KINAXO and Bayer Vital GmbH Collaborate in Phosphoproteomics Biomarker Identification
KINAXO will apply its PhosphoScout® for the identification of novel biomarkers in a clinical trial conducted by Bayer Vital.
Thursday, October 29, 2009
Kinaxo Contributes its Quantitative Phosphoproteomics Platform to a Drug Efficiency Study
Company receives a grant by the Bavarian Research Foundation to expand applications for its quantitative phosphoproteomics platform.
Thursday, February 26, 2009
 
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv